BioVie ( (BIVI) ) just unveiled an update.
BioVie Inc. announced a direct stock offering and a private placement, aiming to raise approximately $6.66 million through the sale of shares at $1.50 each. Additionally, the company will issue warrants exercisable for shares at $1.37 per share. These funds are intended for working capital and corporate purposes, with the offering closing expected on October 22, 2024. The company is focused on developing treatments for liver and neurological diseases.
For an in-depth examination of BIVI stock, go to TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
